| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |